SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-097809
Filing Date
2017-03-27
Accepted
2017-03-27 17:06:58
Documents
4
Period of Report
2017-03-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d349098d8k.htm 8-K 20097
2 EX-5.1 d349098dex51.htm EX-5.1 8016
3 EX-10.1 d349098dex101.htm EX-10.1 140839
4 GRAPHIC g349098img001.jpg GRAPHIC 8810
  Complete submission text file 0001193125-17-097809.txt   182397
Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36548 | Film No.: 17716037
SIC: 2836 Biological Products, (No Diagnostic Substances)